Related Experiment Video

Updated: Feb 17, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

13.3K

Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression

Venkatakrishna R Jala1,2, Paramahamsa Maturu1,2, Sobha R Bodduluri1,2

  • 1James Graham Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, KY, USA.

Oncoimmunology
|December 7, 2017
PubMed

Insights

Mice lacking leukotriene B4 receptor 1 (BLT1) showed increased colon tumor development due to altered gut microbiota and impaired infection response. Restoring normal microbial sensing mechanisms protected these mice from tumors.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Inflammation and infection are known drivers of colon cancer.
  • Leukotriene B4 receptor 1 (BLT1) deficiency protects against inflammatory diseases but its role in colon cancer is unclear.

Purpose of the Study:

  • To investigate the role of BLT1 in colon tumor development and its interplay with microbial sensing pathways.

Main Methods:

  • Utilized BLT1-deficient (BLT1-/-) mice crossed with a spontaneous tumor model (ApcMin/+) and MyD88-deficient mice.
  • Employed germ-free conditions and fecal transplantation experiments.
  • Administered broad-spectrum antibiotics to assess the impact of microbiota manipulation.

Main Results:

  • BLT1-/-ApcMin/+ mice exhibited accelerated intestinal tumor development and mortality, linked to increased inflammation and defective host response to infection.
  • Germ-free BLT1-/-ApcMin/+ mice were tumor-free, with tumors reappearing after fecal transplantation.
  • Microbiota analysis revealed that defective host response in BLT1-/-ApcMin/+ mice reshaped the gut microbiota, promoting colon tumor development.
  • BLT1-/-MyD88-/- mice showed susceptibility to neonatal infections, which was mitigated by antibiotics. Double-deficient BLT1-/-MyD88-/-ApcMin/+ mice were protected from colon tumors.

Conclusions:

  • BLT1 plays a critical role in controlling colon tumor development.
  • A novel interplay exists between Toll-like receptor-mediated microbial sensing and BLT1-mediated host response in colon cancer.
  • Targeting BLT1 and microbial sensing pathways may offer therapeutic strategies for colon cancer.
Keywords:
BLT1Colon cancerMyD88chemokineshost responseinflammationinflammation and cancerleukotriene B4microbiota

More Related Videos

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

3.3K
A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model08:14

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

Published on: February 28, 2018

9.4K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
18
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.7K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.7K